Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
Clinical trial NCT07595276 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07595276
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-10-01
- Enrollment
- 608
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.